<?xml version="1.0" encoding="UTF-8"?>
<ref id="B102-jcm-09-02084">
 <label>102.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meyerowitz</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Vannier</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Friesen</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Schoenfeld</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gelfand</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Callahan</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>A.Y.</given-names>
   </name>
   <name>
    <surname>Reeves</surname>
    <given-names>P.M.</given-names>
   </name>
   <name>
    <surname>Poznansky</surname>
    <given-names>M.C.</given-names>
   </name>
  </person-group>
  <article-title>Rethinking the Role of Hydroxychloroquine in the Treatment of COVID-19</article-title>
  <source>FASEB J.</source>
  <year>2020</year>
  <volume>34</volume>
  <fpage>6027</fpage>
  <lpage>6037</lpage>
  <pub-id pub-id-type="doi">10.1096/fj.202000919</pub-id>
  <pub-id pub-id-type="pmid">32350928</pub-id>
 </element-citation>
</ref>
